ANDA 75250, held by Bausch. Prednisolone Sodium Phosphate.
As of Nov 16, 2026, ANDA 75250 (Prednisolone Sodium Phosphate), held by Bausch, was first approved by FDA on Jul 12, 2002, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 12, 2002 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisolone Sodium PhosphateEQ 15MG BASE/5ML ยท solution;oral | Prednisolone Sodium Phosphate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters